These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16733508)

  • 1. First trimester screening for congenital heart disease.
    Neuman A; Huhta JC
    Minerva Cardioangiol; 2006 Jun; 54(3):337-54. PubMed ID: 16733508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early fetal ultrasound screening for major congenital heart defects without Doppler.
    García Fernández S; Arenas Ramirez J; Otero Chouza MT; Rodriguez-Vijande Alonso B; Llaneza Coto ÁP
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():93-97. PubMed ID: 30580230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How successful is fetal echocardiographic examination in the first trimester of pregnancy?
    Haak MC; Twisk JW; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):9-13. PubMed ID: 12100411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.
    Bahado-Singh RO; Wapner R; Thom E; Zachary J; Platt L; Mahoney MJ; Johnson A; Silver RK; Pergament E; Filkins K; Hogge WA; Wilson RD; Jackson LG;
    Am J Obstet Gynecol; 2005 May; 192(5):1357-61. PubMed ID: 15902108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester fetal heart block and increased nuchal translucency: an indication for early fetal echocardiography.
    Sciarrone A; Masturzo B; Botta G; Bastonero S; Campogrande M; Viora E
    Prenat Diagn; 2005 Dec; 25(12):1129-32. PubMed ID: 16231299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for congenital heart defects by transabdominal ultrasound - role of early gestational screening and importance of operator training.
    Sarkola T; Ojala TH; Ulander VM; Jaeggi E; Pitkänen OM
    Acta Obstet Gynecol Scand; 2015 Mar; 94(3):231-5. PubMed ID: 25545405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early fetal anatomy screening: who, what, when and why?
    Van Mieghem T; Hindryckx A; Van Calsteren K
    Curr Opin Obstet Gynecol; 2015 Apr; 27(2):143-50. PubMed ID: 25689240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester screening for congenital heart disease.
    Huhta JC
    Curr Opin Cardiol; 2016 Jan; 31(1):72-7. PubMed ID: 26627314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy.
    Smrcek JM; Gembruch U; Krokowski M; Berg C; Krapp M; Geipel A; Germer U
    Arch Gynecol Obstet; 2003 Jun; 268(2):94-101. PubMed ID: 12768297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
    Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial Doppler ultrasound in 115 second- and third-trimester fetuses with congenital heart disease.
    Meise C; Germer U; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):398-402. PubMed ID: 11380963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional benefits of first trimester screening.
    D'Alton ME; Cleary-Goldman J
    Semin Perinatol; 2005 Dec; 29(6):405-11. PubMed ID: 16533655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuchal translucency and its relationship to congenital heart disease.
    Devine PC; Simpson LL
    Semin Perinatol; 2000 Oct; 24(5):343-51. PubMed ID: 11071375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study.
    McAuliffe FM; Fong KW; Toi A; Chitayat D; Keating S; Johnson JA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1260-5. PubMed ID: 16157148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.